Long-term persistence of treatment after hip fracture in a fracture liaison service
Long-term persistence of treatment after hip fracture in a fracture liaison service
Source: Scientific reports
Long-term adherence to antiosteoporosis medication (AOM) in the setting of a fracture liaison service (FLS) are not well known. Patients ≥ 50 with hip fracture seen in an FLS and recommended for treatment to prevent new fractures were analyzed.
